nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—Isopropamide—Diphenhydramine—atopic dermatitis	0.171	0.458	CrCrCtD
Darifenacin—CHRM2—Dimenhydrinate—atopic dermatitis	0.156	0.343	CbGbCtD
Darifenacin—Fentanyl—Diphenhydramine—atopic dermatitis	0.104	0.28	CrCrCtD
Darifenacin—Methadone—Diphenhydramine—atopic dermatitis	0.098	0.263	CrCrCtD
Darifenacin—CHRM2—Diphenhydramine—atopic dermatitis	0.0764	0.168	CbGbCtD
Darifenacin—CYP3A4—Pimecrolimus—atopic dermatitis	0.0407	0.0892	CbGbCtD
Darifenacin—CYP2D6—Loratadine—atopic dermatitis	0.0279	0.0611	CbGbCtD
Darifenacin—CYP2D6—Diphenhydramine—atopic dermatitis	0.0279	0.0611	CbGbCtD
Darifenacin—CYP3A4—Tacrolimus—atopic dermatitis	0.0242	0.0531	CbGbCtD
Darifenacin—CYP3A4—Loratadine—atopic dermatitis	0.0177	0.0388	CbGbCtD
Darifenacin—CYP3A4—Methylprednisolone—atopic dermatitis	0.0162	0.0355	CbGbCtD
Darifenacin—CYP3A4—Triamcinolone—atopic dermatitis	0.0123	0.0269	CbGbCtD
Darifenacin—CYP3A4—Betamethasone—atopic dermatitis	0.0105	0.0231	CbGbCtD
Darifenacin—CYP3A4—Prednisolone—atopic dermatitis	0.0104	0.0228	CbGbCtD
Darifenacin—CYP3A4—Hydrocortisone—atopic dermatitis	0.00985	0.0216	CbGbCtD
Darifenacin—CYP3A4—Prednisone—atopic dermatitis	0.00982	0.0215	CbGbCtD
Darifenacin—CYP2D6—Dexamethasone—atopic dermatitis	0.00964	0.0211	CbGbCtD
Darifenacin—CYP3A4—Dexamethasone—atopic dermatitis	0.00613	0.0134	CbGbCtD
Darifenacin—Pain—Tacrolimus—atopic dermatitis	0.00022	0.00136	CcSEcCtD
Darifenacin—Constipation—Tacrolimus—atopic dermatitis	0.00022	0.00136	CcSEcCtD
Darifenacin—Weight increased—Betamethasone—atopic dermatitis	0.00022	0.00136	CcSEcCtD
Darifenacin—Weight increased—Dexamethasone—atopic dermatitis	0.00022	0.00136	CcSEcCtD
Darifenacin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000215	0.00133	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000214	0.00133	CcSEcCtD
Darifenacin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000214	0.00132	CcSEcCtD
Darifenacin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000213	0.00132	CcSEcCtD
Darifenacin—Rhinitis—Triamcinolone—atopic dermatitis	0.000213	0.00132	CcSEcCtD
Darifenacin—Rhinitis—Methylprednisolone—atopic dermatitis	0.000213	0.00132	CcSEcCtD
Darifenacin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000212	0.00131	CcSEcCtD
Darifenacin—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000212	0.00131	CcSEcCtD
Darifenacin—Hallucination—Methylprednisolone—atopic dermatitis	0.000211	0.00131	CcSEcCtD
Darifenacin—Pharyngitis—Triamcinolone—atopic dermatitis	0.000211	0.00131	CcSEcCtD
Darifenacin—Eye disorder—Hydrocortisone—atopic dermatitis	0.000211	0.00131	CcSEcCtD
Darifenacin—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000211	0.0013	CcSEcCtD
Darifenacin—Vomiting—Mometasone—atopic dermatitis	0.000206	0.00127	CcSEcCtD
Darifenacin—Visual impairment—Methylprednisolone—atopic dermatitis	0.000205	0.00127	CcSEcCtD
Darifenacin—Rash—Mometasone—atopic dermatitis	0.000204	0.00126	CcSEcCtD
Darifenacin—Dermatitis—Mometasone—atopic dermatitis	0.000204	0.00126	CcSEcCtD
Darifenacin—Abdominal pain—Tacrolimus—atopic dermatitis	0.000204	0.00126	CcSEcCtD
Darifenacin—Headache—Mometasone—atopic dermatitis	0.000203	0.00125	CcSEcCtD
Darifenacin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000201	0.00125	CcSEcCtD
Darifenacin—Eye disorder—Methylprednisolone—atopic dermatitis	0.000198	0.00123	CcSEcCtD
Darifenacin—Mental disorder—Hydrocortisone—atopic dermatitis	0.000198	0.00123	CcSEcCtD
Darifenacin—Erectile dysfunction—Prednisone—atopic dermatitis	0.000194	0.0012	CcSEcCtD
Darifenacin—Angiopathy—Methylprednisolone—atopic dermatitis	0.000193	0.00119	CcSEcCtD
Darifenacin—Hallucination—Dexamethasone—atopic dermatitis	0.000192	0.00119	CcSEcCtD
Darifenacin—Hallucination—Betamethasone—atopic dermatitis	0.000192	0.00119	CcSEcCtD
Darifenacin—Nausea—Mometasone—atopic dermatitis	0.000192	0.00119	CcSEcCtD
Darifenacin—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000191	0.00118	CcSEcCtD
Darifenacin—Weight increased—Prednisone—atopic dermatitis	0.000191	0.00118	CcSEcCtD
Darifenacin—Vision blurred—Prednisolone—atopic dermatitis	0.00019	0.00118	CcSEcCtD
Darifenacin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00019	0.00117	CcSEcCtD
Darifenacin—Visual impairment—Betamethasone—atopic dermatitis	0.000186	0.00115	CcSEcCtD
Darifenacin—Visual impairment—Dexamethasone—atopic dermatitis	0.000186	0.00115	CcSEcCtD
Darifenacin—Mental disorder—Methylprednisolone—atopic dermatitis	0.000186	0.00115	CcSEcCtD
Darifenacin—Asthenia—Tacrolimus—atopic dermatitis	0.000185	0.00114	CcSEcCtD
Darifenacin—Angioedema—Prednisolone—atopic dermatitis	0.000184	0.00114	CcSEcCtD
Darifenacin—Pruritus—Tacrolimus—atopic dermatitis	0.000182	0.00113	CcSEcCtD
Darifenacin—Dysgeusia—Triamcinolone—atopic dermatitis	0.000181	0.00112	CcSEcCtD
Darifenacin—Syncope—Prednisolone—atopic dermatitis	0.000181	0.00112	CcSEcCtD
Darifenacin—Eye disorder—Betamethasone—atopic dermatitis	0.00018	0.00112	CcSEcCtD
Darifenacin—Eye disorder—Dexamethasone—atopic dermatitis	0.00018	0.00112	CcSEcCtD
Darifenacin—Angioedema—Hydrocortisone—atopic dermatitis	0.00018	0.00111	CcSEcCtD
Darifenacin—Back pain—Triamcinolone—atopic dermatitis	0.000179	0.00111	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisolone—atopic dermatitis	0.000177	0.0011	CcSEcCtD
Darifenacin—Syncope—Hydrocortisone—atopic dermatitis	0.000176	0.00109	CcSEcCtD
Darifenacin—Diarrhoea—Tacrolimus—atopic dermatitis	0.000176	0.00109	CcSEcCtD
Darifenacin—Angiopathy—Betamethasone—atopic dermatitis	0.000175	0.00108	CcSEcCtD
Darifenacin—Angiopathy—Dexamethasone—atopic dermatitis	0.000175	0.00108	CcSEcCtD
Darifenacin—Hypertension—Prednisolone—atopic dermatitis	0.000174	0.00108	CcSEcCtD
Darifenacin—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000173	0.00107	CcSEcCtD
Darifenacin—Dizziness—Tacrolimus—atopic dermatitis	0.00017	0.00105	CcSEcCtD
Darifenacin—Hypertension—Hydrocortisone—atopic dermatitis	0.00017	0.00105	CcSEcCtD
Darifenacin—Angioedema—Triamcinolone—atopic dermatitis	0.000169	0.00105	CcSEcCtD
Darifenacin—Angioedema—Methylprednisolone—atopic dermatitis	0.000169	0.00105	CcSEcCtD
Darifenacin—Hallucination—Prednisone—atopic dermatitis	0.000167	0.00104	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000166	0.00103	CcSEcCtD
Darifenacin—Syncope—Triamcinolone—atopic dermatitis	0.000166	0.00103	CcSEcCtD
Darifenacin—Syncope—Methylprednisolone—atopic dermatitis	0.000166	0.00103	CcSEcCtD
Darifenacin—Oedema—Prednisolone—atopic dermatitis	0.000164	0.00102	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000164	0.00102	CcSEcCtD
Darifenacin—Vomiting—Tacrolimus—atopic dermatitis	0.000164	0.00101	CcSEcCtD
Darifenacin—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000163	0.00101	CcSEcCtD
Darifenacin—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000162	0.00101	CcSEcCtD
Darifenacin—Rash—Tacrolimus—atopic dermatitis	0.000162	0.001	CcSEcCtD
Darifenacin—Dermatitis—Tacrolimus—atopic dermatitis	0.000162	0.001	CcSEcCtD
Darifenacin—Shock—Prednisolone—atopic dermatitis	0.000162	0.001	CcSEcCtD
Darifenacin—Cough—Triamcinolone—atopic dermatitis	0.000162	0.001	CcSEcCtD
Darifenacin—Headache—Tacrolimus—atopic dermatitis	0.000161	0.000998	CcSEcCtD
Darifenacin—Oedema—Hydrocortisone—atopic dermatitis	0.000161	0.000994	CcSEcCtD
Darifenacin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000161	0.000994	CcSEcCtD
Darifenacin—Tachycardia—Prednisolone—atopic dermatitis	0.00016	0.000993	CcSEcCtD
Darifenacin—Hypertension—Triamcinolone—atopic dermatitis	0.00016	0.00099	CcSEcCtD
Darifenacin—Hypertension—Methylprednisolone—atopic dermatitis	0.00016	0.000988	CcSEcCtD
Darifenacin—Infection—Hydrocortisone—atopic dermatitis	0.00016	0.000987	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000159	0.000984	CcSEcCtD
Darifenacin—Shock—Hydrocortisone—atopic dermatitis	0.000158	0.000978	CcSEcCtD
Darifenacin—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000157	0.000975	CcSEcCtD
Darifenacin—Arthralgia—Methylprednisolone—atopic dermatitis	0.000157	0.000974	CcSEcCtD
Darifenacin—Eye disorder—Prednisone—atopic dermatitis	0.000157	0.000973	CcSEcCtD
Darifenacin—Tachycardia—Hydrocortisone—atopic dermatitis	0.000157	0.00097	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000156	0.000967	CcSEcCtD
Darifenacin—Skin disorder—Hydrocortisone—atopic dermatitis	0.000156	0.000965	CcSEcCtD
Darifenacin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000155	0.000961	CcSEcCtD
Darifenacin—Dry mouth—Triamcinolone—atopic dermatitis	0.000154	0.000955	CcSEcCtD
Darifenacin—Angioedema—Dexamethasone—atopic dermatitis	0.000154	0.000951	CcSEcCtD
Darifenacin—Angioedema—Betamethasone—atopic dermatitis	0.000154	0.000951	CcSEcCtD
Darifenacin—Nausea—Tacrolimus—atopic dermatitis	0.000153	0.000946	CcSEcCtD
Darifenacin—Angiopathy—Prednisone—atopic dermatitis	0.000153	0.000944	CcSEcCtD
Darifenacin—Confusional state—Methylprednisolone—atopic dermatitis	0.000152	0.000942	CcSEcCtD
Darifenacin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000151	0.000936	CcSEcCtD
Darifenacin—Oedema—Triamcinolone—atopic dermatitis	0.000151	0.000936	CcSEcCtD
Darifenacin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000151	0.000934	CcSEcCtD
Darifenacin—Syncope—Betamethasone—atopic dermatitis	0.000151	0.000933	CcSEcCtD
Darifenacin—Syncope—Dexamethasone—atopic dermatitis	0.000151	0.000933	CcSEcCtD
Darifenacin—Infection—Triamcinolone—atopic dermatitis	0.00015	0.00093	CcSEcCtD
Darifenacin—Infection—Methylprednisolone—atopic dermatitis	0.00015	0.000928	CcSEcCtD
Darifenacin—Shock—Triamcinolone—atopic dermatitis	0.000149	0.000921	CcSEcCtD
Darifenacin—Insomnia—Prednisolone—atopic dermatitis	0.000149	0.00092	CcSEcCtD
Darifenacin—Shock—Methylprednisolone—atopic dermatitis	0.000148	0.000919	CcSEcCtD
Darifenacin—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000148	0.000916	CcSEcCtD
Darifenacin—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000148	0.000914	CcSEcCtD
Darifenacin—Loss of consciousness—Betamethasone—atopic dermatitis	0.000148	0.000914	CcSEcCtD
Darifenacin—Tachycardia—Triamcinolone—atopic dermatitis	0.000148	0.000913	CcSEcCtD
Darifenacin—Mental disorder—Prednisone—atopic dermatitis	0.000147	0.000912	CcSEcCtD
Darifenacin—Tachycardia—Methylprednisolone—atopic dermatitis	0.000147	0.000911	CcSEcCtD
Darifenacin—Skin disorder—Methylprednisolone—atopic dermatitis	0.000147	0.000907	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000146	0.000906	CcSEcCtD
Darifenacin—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000146	0.000905	CcSEcCtD
Darifenacin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000146	0.000903	CcSEcCtD
Darifenacin—Insomnia—Hydrocortisone—atopic dermatitis	0.000145	0.000899	CcSEcCtD
Darifenacin—Hypertension—Dexamethasone—atopic dermatitis	0.000145	0.000898	CcSEcCtD
Darifenacin—Hypertension—Betamethasone—atopic dermatitis	0.000145	0.000898	CcSEcCtD
Darifenacin—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000141	0.000875	CcSEcCtD
Darifenacin—Pain—Prednisolone—atopic dermatitis	0.000141	0.00087	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000139	0.000858	CcSEcCtD
Darifenacin—Vision blurred—Prednisone—atopic dermatitis	0.000138	0.000854	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000138	0.000853	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000137	0.000851	CcSEcCtD
Darifenacin—Pain—Hydrocortisone—atopic dermatitis	0.000137	0.00085	CcSEcCtD
Darifenacin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000137	0.000849	CcSEcCtD
Darifenacin—Oedema—Betamethasone—atopic dermatitis	0.000137	0.000849	CcSEcCtD
Darifenacin—Oedema—Dexamethasone—atopic dermatitis	0.000137	0.000849	CcSEcCtD
Darifenacin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000137	0.000849	CcSEcCtD
Darifenacin—Insomnia—Triamcinolone—atopic dermatitis	0.000137	0.000846	CcSEcCtD
Darifenacin—Insomnia—Methylprednisolone—atopic dermatitis	0.000136	0.000845	CcSEcCtD
Darifenacin—Infection—Dexamethasone—atopic dermatitis	0.000136	0.000844	CcSEcCtD
Darifenacin—Infection—Betamethasone—atopic dermatitis	0.000136	0.000844	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisolone—atopic dermatitis	0.000136	0.000839	CcSEcCtD
Darifenacin—Shock—Dexamethasone—atopic dermatitis	0.000135	0.000835	CcSEcCtD
Darifenacin—Shock—Betamethasone—atopic dermatitis	0.000135	0.000835	CcSEcCtD
Darifenacin—Dyspnoea—Triamcinolone—atopic dermatitis	0.000135	0.000834	CcSEcCtD
Darifenacin—Nervous system disorder—Betamethasone—atopic dermatitis	0.000135	0.000833	CcSEcCtD
Darifenacin—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000135	0.000833	CcSEcCtD
Darifenacin—Tachycardia—Dexamethasone—atopic dermatitis	0.000134	0.000829	CcSEcCtD
Darifenacin—Tachycardia—Betamethasone—atopic dermatitis	0.000134	0.000829	CcSEcCtD
Darifenacin—Angioedema—Prednisone—atopic dermatitis	0.000134	0.000828	CcSEcCtD
Darifenacin—Dyspepsia—Triamcinolone—atopic dermatitis	0.000133	0.000824	CcSEcCtD
Darifenacin—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000133	0.000822	CcSEcCtD
Darifenacin—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000133	0.000821	CcSEcCtD
Darifenacin—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000133	0.000821	CcSEcCtD
Darifenacin—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000132	0.000819	CcSEcCtD
Darifenacin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000131	0.000813	CcSEcCtD
Darifenacin—Syncope—Prednisone—atopic dermatitis	0.000131	0.000813	CcSEcCtD
Darifenacin—Pain—Triamcinolone—atopic dermatitis	0.000129	0.0008	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisone—atopic dermatitis	0.000129	0.000796	CcSEcCtD
Darifenacin—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000127	0.000786	CcSEcCtD
Darifenacin—Hypertension—Prednisone—atopic dermatitis	0.000126	0.000782	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000125	0.000774	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000125	0.000774	CcSEcCtD
Darifenacin—Arthralgia—Prednisone—atopic dermatitis	0.000125	0.000771	CcSEcCtD
Darifenacin—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000125	0.000771	CcSEcCtD
Darifenacin—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000124	0.000769	CcSEcCtD
Darifenacin—Insomnia—Betamethasone—atopic dermatitis	0.000124	0.000768	CcSEcCtD
Darifenacin—Insomnia—Dexamethasone—atopic dermatitis	0.000124	0.000768	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000124	0.000766	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000123	0.000764	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000121	0.00075	CcSEcCtD
Darifenacin—Dyspepsia—Betamethasone—atopic dermatitis	0.000121	0.000747	CcSEcCtD
Darifenacin—Dyspepsia—Dexamethasone—atopic dermatitis	0.000121	0.000747	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisone—atopic dermatitis	0.000119	0.00074	CcSEcCtD
Darifenacin—Oedema—Prednisone—atopic dermatitis	0.000119	0.00074	CcSEcCtD
Darifenacin—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000119	0.000738	CcSEcCtD
Darifenacin—Infection—Prednisone—atopic dermatitis	0.000119	0.000735	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000118	0.000733	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000118	0.000733	CcSEcCtD
Darifenacin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000118	0.000732	CcSEcCtD
Darifenacin—Shock—Prednisone—atopic dermatitis	0.000118	0.000728	CcSEcCtD
Darifenacin—Pain—Betamethasone—atopic dermatitis	0.000117	0.000726	CcSEcCtD
Darifenacin—Pain—Dexamethasone—atopic dermatitis	0.000117	0.000726	CcSEcCtD
Darifenacin—Nervous system disorder—Prednisone—atopic dermatitis	0.000117	0.000725	CcSEcCtD
Darifenacin—Tachycardia—Prednisone—atopic dermatitis	0.000117	0.000722	CcSEcCtD
Darifenacin—Skin disorder—Prednisone—atopic dermatitis	0.000116	0.000718	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisone—atopic dermatitis	0.000116	0.000715	CcSEcCtD
Darifenacin—Asthenia—Hydrocortisone—atopic dermatitis	0.000115	0.000713	CcSEcCtD
Darifenacin—Pruritus—Hydrocortisone—atopic dermatitis	0.000114	0.000703	CcSEcCtD
Darifenacin—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000113	0.0007	CcSEcCtD
Darifenacin—Feeling abnormal—Betamethasone—atopic dermatitis	0.000113	0.0007	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000112	0.000694	CcSEcCtD
Darifenacin—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000112	0.000694	CcSEcCtD
Darifenacin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000111	0.00069	CcSEcCtD
Darifenacin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000111	0.000688	CcSEcCtD
Darifenacin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00011	0.00068	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000109	0.000674	CcSEcCtD
Darifenacin—Dizziness—Prednisolone—atopic dermatitis	0.000109	0.000673	CcSEcCtD
Darifenacin—Asthenia—Triamcinolone—atopic dermatitis	0.000108	0.000671	CcSEcCtD
Darifenacin—Abdominal pain—Dexamethasone—atopic dermatitis	0.000108	0.000671	CcSEcCtD
Darifenacin—Abdominal pain—Betamethasone—atopic dermatitis	0.000108	0.000671	CcSEcCtD
Darifenacin—Asthenia—Methylprednisolone—atopic dermatitis	0.000108	0.00067	CcSEcCtD
Darifenacin—Insomnia—Prednisone—atopic dermatitis	0.000108	0.000669	CcSEcCtD
Darifenacin—Pruritus—Triamcinolone—atopic dermatitis	0.000107	0.000662	CcSEcCtD
Darifenacin—Pruritus—Methylprednisolone—atopic dermatitis	0.000107	0.000661	CcSEcCtD
Darifenacin—Dizziness—Hydrocortisone—atopic dermatitis	0.000106	0.000657	CcSEcCtD
Darifenacin—Dyspepsia—Prednisone—atopic dermatitis	0.000105	0.000651	CcSEcCtD
Darifenacin—Rash—Prednisolone—atopic dermatitis	0.000104	0.000642	CcSEcCtD
Darifenacin—Dermatitis—Prednisolone—atopic dermatitis	0.000104	0.000641	CcSEcCtD
Darifenacin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000103	0.000639	CcSEcCtD
Darifenacin—Headache—Prednisolone—atopic dermatitis	0.000103	0.000638	CcSEcCtD
Darifenacin—Constipation—Prednisone—atopic dermatitis	0.000102	0.000632	CcSEcCtD
Darifenacin—Vomiting—Hydrocortisone—atopic dermatitis	0.000102	0.000632	CcSEcCtD
Darifenacin—Rash—Hydrocortisone—atopic dermatitis	0.000101	0.000627	CcSEcCtD
Darifenacin—Dermatitis—Hydrocortisone—atopic dermatitis	0.000101	0.000626	CcSEcCtD
Darifenacin—Headache—Hydrocortisone—atopic dermatitis	0.000101	0.000623	CcSEcCtD
Darifenacin—Dizziness—Triamcinolone—atopic dermatitis	0.0001	0.000619	CcSEcCtD
Darifenacin—Dizziness—Methylprednisolone—atopic dermatitis	9.98e-05	0.000617	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisone—atopic dermatitis	9.85e-05	0.000609	CcSEcCtD
Darifenacin—Asthenia—Betamethasone—atopic dermatitis	9.84e-05	0.000609	CcSEcCtD
Darifenacin—Asthenia—Dexamethasone—atopic dermatitis	9.84e-05	0.000609	CcSEcCtD
Darifenacin—Gastrointestinal pain—Prednisone—atopic dermatitis	9.77e-05	0.000605	CcSEcCtD
Darifenacin—Nausea—Prednisolone—atopic dermatitis	9.77e-05	0.000604	CcSEcCtD
Darifenacin—Pruritus—Betamethasone—atopic dermatitis	9.71e-05	0.000601	CcSEcCtD
Darifenacin—Pruritus—Dexamethasone—atopic dermatitis	9.71e-05	0.000601	CcSEcCtD
Darifenacin—Vomiting—Triamcinolone—atopic dermatitis	9.61e-05	0.000595	CcSEcCtD
Darifenacin—Vomiting—Methylprednisolone—atopic dermatitis	9.59e-05	0.000594	CcSEcCtD
Darifenacin—Nausea—Hydrocortisone—atopic dermatitis	9.54e-05	0.00059	CcSEcCtD
Darifenacin—Rash—Triamcinolone—atopic dermatitis	9.53e-05	0.00059	CcSEcCtD
Darifenacin—Dermatitis—Triamcinolone—atopic dermatitis	9.53e-05	0.00059	CcSEcCtD
Darifenacin—Rash—Methylprednisolone—atopic dermatitis	9.51e-05	0.000589	CcSEcCtD
Darifenacin—Dermatitis—Methylprednisolone—atopic dermatitis	9.5e-05	0.000588	CcSEcCtD
Darifenacin—Headache—Triamcinolone—atopic dermatitis	9.47e-05	0.000586	CcSEcCtD
Darifenacin—Headache—Methylprednisolone—atopic dermatitis	9.45e-05	0.000585	CcSEcCtD
Darifenacin—Abdominal pain—Prednisone—atopic dermatitis	9.45e-05	0.000585	CcSEcCtD
Darifenacin—Diarrhoea—Dexamethasone—atopic dermatitis	9.39e-05	0.000581	CcSEcCtD
Darifenacin—Diarrhoea—Betamethasone—atopic dermatitis	9.39e-05	0.000581	CcSEcCtD
Darifenacin—Dizziness—Dexamethasone—atopic dermatitis	9.07e-05	0.000562	CcSEcCtD
Darifenacin—Dizziness—Betamethasone—atopic dermatitis	9.07e-05	0.000562	CcSEcCtD
Darifenacin—Nausea—Triamcinolone—atopic dermatitis	8.98e-05	0.000556	CcSEcCtD
Darifenacin—Nausea—Methylprednisolone—atopic dermatitis	8.96e-05	0.000555	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisone—atopic dermatitis	8.8e-05	0.000545	CcSEcCtD
Darifenacin—Vomiting—Dexamethasone—atopic dermatitis	8.72e-05	0.00054	CcSEcCtD
Darifenacin—Vomiting—Betamethasone—atopic dermatitis	8.72e-05	0.00054	CcSEcCtD
Darifenacin—Rash—Dexamethasone—atopic dermatitis	8.65e-05	0.000535	CcSEcCtD
Darifenacin—Rash—Betamethasone—atopic dermatitis	8.65e-05	0.000535	CcSEcCtD
Darifenacin—Dermatitis—Dexamethasone—atopic dermatitis	8.64e-05	0.000535	CcSEcCtD
Darifenacin—Dermatitis—Betamethasone—atopic dermatitis	8.64e-05	0.000535	CcSEcCtD
Darifenacin—Headache—Dexamethasone—atopic dermatitis	8.6e-05	0.000532	CcSEcCtD
Darifenacin—Headache—Betamethasone—atopic dermatitis	8.6e-05	0.000532	CcSEcCtD
Darifenacin—Asthenia—Prednisone—atopic dermatitis	8.57e-05	0.000531	CcSEcCtD
Darifenacin—Pruritus—Prednisone—atopic dermatitis	8.45e-05	0.000523	CcSEcCtD
Darifenacin—Diarrhoea—Prednisone—atopic dermatitis	8.18e-05	0.000506	CcSEcCtD
Darifenacin—Nausea—Dexamethasone—atopic dermatitis	8.15e-05	0.000504	CcSEcCtD
Darifenacin—Nausea—Betamethasone—atopic dermatitis	8.15e-05	0.000504	CcSEcCtD
Darifenacin—Dizziness—Prednisone—atopic dermatitis	7.9e-05	0.000489	CcSEcCtD
Darifenacin—Vomiting—Prednisone—atopic dermatitis	7.6e-05	0.00047	CcSEcCtD
Darifenacin—Rash—Prednisone—atopic dermatitis	7.53e-05	0.000466	CcSEcCtD
Darifenacin—Dermatitis—Prednisone—atopic dermatitis	7.53e-05	0.000466	CcSEcCtD
Darifenacin—Headache—Prednisone—atopic dermatitis	7.49e-05	0.000463	CcSEcCtD
Darifenacin—Nausea—Prednisone—atopic dermatitis	7.1e-05	0.000439	CcSEcCtD
Darifenacin—CHRM4—GPCR downstream signaling—TAC1—atopic dermatitis	1.9e-05	0.00199	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—NPS—atopic dermatitis	1.9e-05	0.00199	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCR3—atopic dermatitis	1.86e-05	0.00195	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL27—atopic dermatitis	1.86e-05	0.00195	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCR3—atopic dermatitis	1.85e-05	0.00194	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.83e-05	0.00192	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	1.83e-05	0.00192	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.82e-05	0.00191	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—TAC1—atopic dermatitis	1.82e-05	0.00191	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—NPS—atopic dermatitis	1.82e-05	0.00191	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.8e-05	0.00189	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	1.79e-05	0.00188	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	1.79e-05	0.00188	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	1.78e-05	0.00187	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	1.77e-05	0.00186	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	1.76e-05	0.00185	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	1.74e-05	0.00182	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	1.72e-05	0.00181	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	1.72e-05	0.00181	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	1.69e-05	0.00177	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	1.69e-05	0.00177	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	1.66e-05	0.00175	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	1.65e-05	0.00173	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	1.65e-05	0.00173	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.64e-05	0.00172	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	1.62e-05	0.0017	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	1.6e-05	0.00168	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	1.6e-05	0.00168	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	1.59e-05	0.00167	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	1.58e-05	0.00166	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	1.58e-05	0.00165	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	1.57e-05	0.00165	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.57e-05	0.00165	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	1.56e-05	0.00163	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	1.55e-05	0.00163	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	1.54e-05	0.00162	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	1.54e-05	0.00162	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	1.53e-05	0.00161	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	1.52e-05	0.0016	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	1.5e-05	0.00158	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GLB1—atopic dermatitis	1.49e-05	0.00156	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	1.48e-05	0.00156	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	1.47e-05	0.00154	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	1.46e-05	0.00153	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	1.45e-05	0.00152	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	1.44e-05	0.00151	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	1.44e-05	0.00151	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	1.43e-05	0.0015	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ADSL—atopic dermatitis	1.42e-05	0.00149	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	1.42e-05	0.00149	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	1.4e-05	0.00147	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	1.4e-05	0.00147	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	1.39e-05	0.00146	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	1.39e-05	0.00146	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	1.38e-05	0.00145	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	1.37e-05	0.00144	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.37e-05	0.00144	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	1.37e-05	0.00143	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	1.34e-05	0.00141	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	1.34e-05	0.00141	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.33e-05	0.00139	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	1.32e-05	0.00138	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	1.31e-05	0.00137	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	1.31e-05	0.00137	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	1.3e-05	0.00137	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	1.3e-05	0.00137	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	1.3e-05	0.00136	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	1.29e-05	0.00136	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	1.29e-05	0.00135	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	1.29e-05	0.00135	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	1.28e-05	0.00134	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	1.28e-05	0.00134	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	1.28e-05	0.00134	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	1.28e-05	0.00134	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	1.26e-05	0.00133	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	1.26e-05	0.00133	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	1.26e-05	0.00132	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.25e-05	0.00132	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	1.25e-05	0.00131	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	1.25e-05	0.00131	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	1.24e-05	0.0013	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	1.24e-05	0.0013	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	1.19e-05	0.00125	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.19e-05	0.00125	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	1.19e-05	0.00125	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	1.19e-05	0.00124	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	1.18e-05	0.00123	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	1.17e-05	0.00123	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	1.17e-05	0.00123	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	1.17e-05	0.00123	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	1.17e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	1.16e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	1.16e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	1.16e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	1.16e-05	0.00122	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	1.16e-05	0.00121	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	1.15e-05	0.0012	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	1.15e-05	0.0012	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	1.14e-05	0.0012	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	1.14e-05	0.0012	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	1.14e-05	0.00119	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	1.13e-05	0.00118	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	1.12e-05	0.00118	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	1.12e-05	0.00117	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.1e-05	0.00116	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.1e-05	0.00116	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	1.09e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.09e-05	0.00114	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	1.08e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	1.08e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.07e-05	0.00112	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	1.07e-05	0.00112	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	1.06e-05	0.00111	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	1.04e-05	0.0011	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	1.04e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	1.03e-05	0.00108	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	1.02e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NPS—atopic dermatitis	1.02e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	1.01e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.01e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	1.01e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	1e-05	0.00105	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	9.98e-06	0.00105	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NPS—atopic dermatitis	9.75e-06	0.00102	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	9.75e-06	0.00102	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	9.56e-06	0.001	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL5—atopic dermatitis	9.46e-06	0.000993	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	9.44e-06	0.000991	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	9.44e-06	0.000991	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	9.41e-06	0.000988	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	9.41e-06	0.000988	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	9.32e-06	0.000978	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	9.32e-06	0.000978	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	9.21e-06	0.000966	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	9.18e-06	0.000963	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	9.09e-06	0.000954	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL5—atopic dermatitis	9.06e-06	0.000951	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GLB1—atopic dermatitis	8.88e-06	0.000932	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	8.88e-06	0.000932	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	8.85e-06	0.000929	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	8.84e-06	0.000928	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	8.77e-06	0.00092	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	8.73e-06	0.000916	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	8.7e-06	0.000913	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	8.62e-06	0.000904	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ADSL—atopic dermatitis	8.52e-06	0.000894	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	8.41e-06	0.000883	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	8.39e-06	0.00088	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	8.38e-06	0.000879	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	8.35e-06	0.000877	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	8.3e-06	0.000871	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	8.07e-06	0.000847	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	7.93e-06	0.000832	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	7.9e-06	0.000829	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	7.86e-06	0.000825	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	7.84e-06	0.000823	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	7.82e-06	0.000821	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	7.76e-06	0.000815	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	7.73e-06	0.000811	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	7.7e-06	0.000808	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	7.67e-06	0.000805	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	7.6e-06	0.000797	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	7.14e-06	0.000749	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	7.12e-06	0.000747	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	7.05e-06	0.00074	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	7.05e-06	0.00074	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	6.94e-06	0.000729	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	6.86e-06	0.00072	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NPS—atopic dermatitis	6.86e-06	0.00072	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	6.84e-06	0.000718	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NPS—atopic dermatitis	6.84e-06	0.000718	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	6.77e-06	0.000711	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NPS—atopic dermatitis	6.77e-06	0.000711	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	6.75e-06	0.000709	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	6.74e-06	0.000707	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	6.73e-06	0.000706	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	6.71e-06	0.000704	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	6.65e-06	0.000698	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	6.64e-06	0.000697	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	6.45e-06	0.000677	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NGF—atopic dermatitis	6.43e-06	0.000675	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	6.4e-06	0.000672	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL5—atopic dermatitis	6.38e-06	0.000669	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL5—atopic dermatitis	6.36e-06	0.000667	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL5—atopic dermatitis	6.3e-06	0.000661	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	6.26e-06	0.000656	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NGF—atopic dermatitis	6.16e-06	0.000646	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	6.13e-06	0.000643	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	6.12e-06	0.000642	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	5.99e-06	0.000629	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	5.86e-06	0.000615	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GLB1—atopic dermatitis	5.81e-06	0.000609	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADSL—atopic dermatitis	5.57e-06	0.000584	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	5.44e-06	0.000571	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	5.42e-06	0.000569	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	5.37e-06	0.000563	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	5.3e-06	0.000557	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	5.08e-06	0.000533	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARA—atopic dermatitis	4.82e-06	0.000506	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.75e-06	0.000499	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	4.74e-06	0.000497	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.69e-06	0.000492	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	4.68e-06	0.000491	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	4.67e-06	0.00049	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	4.62e-06	0.000485	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	4.54e-06	0.000477	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	4.53e-06	0.000475	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	4.48e-06	0.000471	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NGF—atopic dermatitis	4.34e-06	0.000455	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NGF—atopic dermatitis	4.32e-06	0.000454	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	4.32e-06	0.000453	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	4.3e-06	0.000452	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NGF—atopic dermatitis	4.28e-06	0.000449	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	4.26e-06	0.000447	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	4.22e-06	0.000443	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	4.2e-06	0.000441	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	4.16e-06	0.000437	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	4.13e-06	0.000433	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	4.11e-06	0.000432	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	4.07e-06	0.000427	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	3.78e-06	0.000397	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	3.62e-06	0.00038	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2—atopic dermatitis	3.61e-06	0.000379	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	3.6e-06	0.000377	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.58e-06	0.000375	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	3.56e-06	0.000374	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	3.53e-06	0.00037	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2—atopic dermatitis	3.46e-06	0.000363	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	3.44e-06	0.000361	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	3.33e-06	0.000349	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	3.19e-06	0.000334	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.88e-06	0.000302	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.55e-06	0.000268	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	2.54e-06	0.000267	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	2.52e-06	0.000264	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2—atopic dermatitis	2.44e-06	0.000256	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2—atopic dermatitis	2.43e-06	0.000255	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	2.43e-06	0.000254	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	2.42e-06	0.000254	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2—atopic dermatitis	2.41e-06	0.000252	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	2.39e-06	0.000251	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.24e-06	0.000235	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	2.24e-06	0.000235	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	2.21e-06	0.000232	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—atopic dermatitis	2.12e-06	0.000223	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—atopic dermatitis	2.03e-06	0.000214	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.88e-06	0.000198	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—atopic dermatitis	1.43e-06	0.00015	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—atopic dermatitis	1.43e-06	0.00015	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—atopic dermatitis	1.41e-06	0.000148	CbGpPWpGaD
